SCHEMBL6071191

SCHEMBL6071191

CCn1c2c(c3ccccc31)CCCc1c(C(=O)O)n[nH]c1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.47
ALDH1A1 P00352 7/20 0.47
HSD17B10 Q99714 4/20 0.47
HPGD P15428 3/20 0.47
TSHR P16473 1/20 0.47
PDE5A O76074 2/20 0.46
POLB P06746 1/20 0.45
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GLA P06280 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
CREBBP Q92793 1/20 0.41
HCAR2 Q8TDS4 1/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
MAPK1 P28482 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071467 0.75 PDE5A (0.47) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL275697 0.70 KDM4E (0.49) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL6071280 0.67 PDE5A (0.49) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL797767 0.66 PDE5A (0.52) KDM4EALDH1A1HSD17B10HPGDPDE5A
SCHEMBL6071395 0.66 AURKA (0.50) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL6071197 0.65 ALDH1A1 (0.56) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL6071189 0.65 HSD17B10 (0.45) KDM4EALDH1A1HSD17B10HPGDTSHR
Hydrochloric Acid SCHEMBL6070901 0.65 AURKA (0.49) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL6071587 0.64 KDM4E (0.45) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL30184445 0.64 CA1 (0.71) KDM4EALDH1A1HSD17B10TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K1, MAP3K19, MAP3K20 KDM4E 1799/4885ALDH1A1 4446/4885HSD17B10 4387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.